A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
about
NPS: Medical Consequences Associated with Their IntakeReports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.Focus on cannabinoids and synthetic cannabinoids.Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.Case Series of Synthetic Cannabinoid Intoxication from One Toxicology CenterStrategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes.Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats.Interpretation of Workplace Tests for Cannabinoids.Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature.The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.Alterations of the hematologic cells in synthetic cannabinoid users.Medical cannabis: Another piece in the mosaic of autoimmunity?[Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.Synthetic Cannabinoid Use Among High School Seniors.The Growing Problem of New Psychoactive Substances (NPS).Understanding the Link Between Cannabinoids and Psychosis.Role of cannabis in cardiovascular disorders.Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion.Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.Cannabis, cannabinoids, and health.Four analytically confirmed cases of use of third-generation synthetic cannabinoid receptor agonists incorporating an adamantyl group.Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use.JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up.The dark cloud of recreational drugs and vaping.Acute pain management in patients with drug dependence syndrome.Systematic review and meta-analysis of cannabinoids in palliative medicine.The Consumption of New Psychoactive Substances and Methamphetamine.Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.Repeated Exposure to the "Spice" Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats.
P2860
Q28276182-8E8D3989-B213-4D38-B358-7FA693D6CC43Q30148688-841AB11F-4521-493C-9B08-56F5538FB5DEQ30241053-EE3679DF-5E70-46B6-8D37-AD5BE3BE5FE4Q31154576-E661D69C-E209-416F-869B-035AA39D69B8Q33167207-E7728AA6-9BCC-40CE-A537-85172F0714B8Q34529280-92F0621B-AA21-4591-A010-E91B9FED93C7Q34540515-69007762-8D7A-4973-9D61-CC9644D808E9Q36983930-630A1F68-5EA3-4F1D-B441-5CAE596BC58DQ37146958-0C8DB67D-341F-42A6-ACB2-05D5A0DDE16DQ37274656-DACDECE7-B931-4F75-84CA-DB4C66D0D860Q37637031-486603E2-6940-4239-ACED-A8C7A2C38A1DQ38376082-44E57393-6D5D-46F6-BBFD-CC1CEB33B886Q38764828-B895E74B-9C9C-4F58-8FBA-EF00A719EB4FQ38816377-97FC5503-E441-4E5E-A4AA-096C5DE33A26Q38830962-FA3049A6-DBEA-4AB8-86B9-D3E35BD4B84AQ38903033-1E100900-84A1-48FA-94BD-0386B6EA66C0Q38949998-072F60AF-37CA-4017-BA35-A51EF6FA3280Q38973739-2DF12DBA-4A40-45FD-B4C7-4EED40528648Q38974502-4D2BC40E-4087-4BC2-9FD5-B63416C83A65Q39012168-8320C44E-A49F-4670-BAFE-B62770F37EF1Q39177603-48CCD6B5-B44B-43B1-923F-F030E4F281DEQ39714833-CE550958-E7E3-429C-A952-C5102EC3CB40Q39841753-6334CF6A-231D-45BC-A73E-6AD43EE7D385Q40046737-CF8951EB-20E8-46B8-BCC0-0E61C33F0DFBQ40603293-077160CA-4BA1-4A6B-AC78-82BB007D3A69Q40671558-BB425917-FF90-445B-A1D0-C252B15D1E1AQ41242026-7BCAB951-C461-4813-B9CD-41E810FE79A8Q41962199-04FE75EA-0903-4FBA-8D8E-E8E1904FF7C2Q45985987-99DAB8AA-C6D4-4DAE-8B87-D0AA0A91C283Q47139391-B5598AF9-4560-4CBD-9B92-F323EBFBC0C3Q47438017-4ED2E6B3-0707-4C36-974B-F55029EAC052Q47598189-C17FDA1F-CD50-43A8-B285-2F5AF185D972Q47682925-6B19AE1E-0A56-48E6-A170-FB62470476F4Q47740693-CFC16829-36AF-4632-8CD3-E55EC3693000Q47941849-7F082CE8-40F6-4BFE-B47D-46DCD2A18351Q49384652-B3E486D9-D51F-435C-A1BD-368C97A38A71Q50201189-0D1E33B1-0148-4CD3-ABA9-6EBA810FA5C3Q50329792-33710203-6E21-4562-AF4E-C2173B138ADBQ52651312-DF5A32AF-9469-4290-8EFA-FBB4B550B751Q52657192-C674D129-54F4-437A-B261-69478F167C72
P2860
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A systematic review of adverse ...... nd their associated treatment.
@ast
A systematic review of adverse ...... nd their associated treatment.
@en
A systematic review of adverse ...... nd their associated treatment.
@nl
type
label
A systematic review of adverse ...... nd their associated treatment.
@ast
A systematic review of adverse ...... nd their associated treatment.
@en
A systematic review of adverse ...... nd their associated treatment.
@nl
prefLabel
A systematic review of adverse ...... nd their associated treatment.
@ast
A systematic review of adverse ...... nd their associated treatment.
@en
A systematic review of adverse ...... nd their associated treatment.
@nl
P2860
P50
P1433
P1476
A systematic review of adverse ...... and their associated treatment
@en
P2093
David Mountain
Simon L Hill
P2860
P356
10.3109/15563650.2015.1110590
P407
P577
2015-11-15T00:00:00Z